Astrazeneca (AZN) EPS (Diluted) (2009 - 2026)
Astrazeneca (AZN) recorded EPS (Diluted) of $1.85 in Q2 2026, down 18.6% from $2.28 a year earlier and down 6.1% from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) EPS (Diluted) (2009 - 2026) Analysis & Trends
On a TTM basis, Astrazeneca's EPS (Diluted) came in at $6.96 as of Jun 30, 2026, up 2.4% year-over-year; for FY2025, it came in at $6.55, up 45.4% from FY2024.
- Annual EPS (Diluted) has increased for three straight years, with a five-year compound annual growth rate of 21.9% (FY2020 to FY2025).
- Across earlier years, EPS (Diluted) came in at $4.50 in FY2024 (+18.1%), $3.81 in FY2023 (+80.9%), $2.11 in FY2022 and $0.08 in FY2021 (-96.8%).
- Quarterly EPS (Diluted) has ranged from -$1.51 in Q3 2021 to $2.28 in Q2 2025 over the past five years.
- On a year-over-year basis, EPS (Diluted) rose in five of the last eight quarters, with growth averaging 35.5%.
- Peak year-over-year performance for EPS (Diluted) in the last five years was growth of 392.6% in Q1 2023, against a decline of 76.1% in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.97 (Q1 2026), $1.49 (Q4 2025) and $1.65 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.67 |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.85 |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 4.37 |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -8.44 |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -0.04 |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 4.31 |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn | 1.62 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.85 |
| Mar 31, 2026 | 1.97 |
| Dec 31, 2025 | 1.49 |
| Sep 30, 2025 | 1.65 |
| Jun 30, 2025 | 2.28 |
| Mar 31, 2025 | 1.87 |
| Dec 31, 2024 | 0.96 |
| Sep 30, 2024 | 1.70 |
| Jun 30, 2024 | 1.24 |
| Mar 31, 2024 | 1.13 |
| Dec 31, 2023 | 1.14 |
| Sep 30, 2023 | 0.80 |
| Jun 30, 2023 | 0.94 |
| Mar 31, 2023 | 1.40 |
| Dec 31, 2022 | 1.10 |
| Sep 30, 2022 | 0.47 |
| Jun 30, 2022 | -0.26 |
| Mar 31, 2022 | 0.28 |
| Dec 31, 2021 | -0.52 |
| Sep 30, 2021 | -1.51 |
API Access
Astrazeneca EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();